MicroRNA let-7: Regulation, single nucleotide polymorphism, and therapy in lung cancer

Journal of Cancer Research and Therapeutics

Volumn 11, Issue 5, 2015, Pages C1-C6

  Yang, Guang ^a   Zhang, Wenqi ^b   Yu, Chunlei ^c   Ren, Jin ^d   An, Zhe ^b  

^a JILIN UNIVERSITY   (China)

^b CHINA JAPAN UNION HOSPITAL OF JILIN UNIVERSITY   (China)

^c PR China   (China)

^d THE SECOND HOSPITAL OF JILIN UNIVERSITY   (China)

Author keywords

HMGA2; Let 7; lung cancer; RNA therapy; single nucleotide polymorphism

Indexed keywords

MICRORNA; MICRORNA LET 7; UNCLASSIFIED DRUG; MESSENGER RNA; MIRNLET7 MICRORNA, HUMAN;

CANCER GENE THERAPY; CANCER GROWTH; GENE EXPRESSION; GENE TARGETING; GENETIC REGULATION; HUMAN; LUNG CANCER; META ANALYSIS (TOPIC); NONHUMAN; REVIEW; SINGLE NUCLEOTIDE POLYMORPHISM; SYSTEMATIC REVIEW; GENE EXPRESSION REGULATION; GENETICS; LUNG NEOPLASMS; META ANALYSIS; METABOLISM; MOLECULARLY TARGETED THERAPY; MULTIGENE FAMILY; MUTATION; RNA INTERFERENCE; SIGNAL TRANSDUCTION;

GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LUNG NEOPLASMS; MICRORNAS; MOLECULAR TARGETED THERAPY; MULTIGENE FAMILY; MUTATION; POLYMORPHISM, SINGLE NUCLEOTIDE; RNA INTERFERENCE; RNA, MESSENGER; SIGNAL TRANSDUCTION;

EID: 84940904426     PISSN: 09731482     EISSN: 19984138     Source Type: Journal    
DOI: 10.4103/0973-1482.163830     Document Type: Review

References (47)

1. Zhang W, Zhang Q, Zhang M, Zhang Y, Li F, Lei P. Network analysis in the identification of special mechanisms between small cell lung cancer and non-small cell lung cancer. Thorac Cancer 2014;5:556-64.
2. Mahjub H, Sadri GH. Meta-analysis of case-referent studies of specific environmental or occupational pollutants on lung cancer. Indian J Cancer 2006;43:169-73.
3. Kumar R, Xi Y. MicroRNA, epigenetic machinery and lung cancer. Thorac Cancer 2011;2:35-44.
4. Reinhart BJ, Slack FJ, Basson M, Pasquinelli AE, Bettinger J The 21-nucleotide let-7 RNA regulates developmental timing in Caenorhabditis elegans. Nature 2000;403:901-6.
5. Roush S, Slack FJ. The let-7 family of microRNAs. Trends Cell Biol 2008;18:505-16.
6. Wang X, Cao L, Wang Y, Wang X, Liu N, You Y. Regulation of let-7 and its target oncogenes (Review). Oncol Lett 2012;3:955-960.
7. Brookes AJ. The essence of SNPs. Gene 1999;234:177-86.
8. Shi H, Shu H, Huang C, Gong J, Yang Y, Liu R, et al. Association of LEPR K109R polymorphisms with cancer risk: A systematic review and pooled analysis. J BUON 2014;19:847-54.
9. Chin LJ, Ratner E, Leng S, Zhai R, Nallur S, Babar I, et al. A SNP in a let-7 microRNA complementary site in the KRAS 3' untranslated region increases non-small cell lung cancer risk. Cancer Res 2008;68:8535-40.
10. Osada H, Takahashi T. let-7 and miR-17-92: Small-sized major players in lung cancer development. Cancer Sci 2011;102:9-17.
11. Polo V, Besse B. Maintenance strategies in stage IV non-small-cell lung cancer (NSCLC): In which patients, with which drugs? Ann Oncol 2014;25:1283-93.
12. Siegel R, Naishadham D, Jemal A. Cancer statistics, 2013. CA Cancer J Clin 2013;63:11-30.
13. Takamizawa J, Konishi H, Yanagisawa K, Tomida S, Osada H, Endoh H, et al. Reduced expression of the let-7 microRNAs in human lung cancers in association with shortened postoperative survival. Cancer Res 2004;64:3753-6.
14. Johnson SM, Grosshans H, Shingara J, Byrom M, Jarvis R, Cheng A, et al. RAS is regulated by the let-7 microRNA family. Cell 2005;120:635-47.
15. Lee YS, Dutta A. The tumor suppressor microRNA let-7 represses the HMGA2 oncogene. Genes Dev 2007;21:1025-30.
16. Sampson VB, Rong NH, Han J, Yang Q, Aris V, Soteropoulos P, et al. MicroRNA let-7a down-regulates MYC and reverts MYC-induced growth in Burkitt lymphoma cells. Cancer Res 2007;67:9762-70.
17. Karube Y, Tanaka H, Osada H, Tomida S, Tatematsu Y, Yanagisawa K, et al. Reduced expression of Dicer associated with poor prognosis in lung cancer patients. Cancer Sci 2005;96:111-5.
18. Hertel J, Bartschat S, Wintsche A, Otto C, Students of the Bioinformatics Computer L, Stadler PF. Evolution of the let-7 microRNA family. RNA Biol 2012;9:231-41.
19. Fassina A, Cappellesso R, Fassan M. Classification of non-small cell lung carcinoma in transthoracic needle specimens using microRNA expression profiling. Chest 2011;140:1305-11.
20. Boyerinas B, Park SM, Hau A, Murmann AE, Peter ME. The role of let-7 in cell differentiation and cancer. Endocr Relat Cancer 2010;17:F19-36.
21. Xia XM, Jin WY, Shi RZ, Zhang YF, Chen J. Clinical significance and the correlation of expression between Let-7 and K-ras in non-small cell lung cancer. Oncol Lett 2010;1:1045-7.
22. Guan H, Zhang P, Liu C, Zhang J, Huang Z, Chen W, et al. Characterization and functional analysis of the human microRNA let-7a2 promoter in lung cancer A549 cell lines. Mol Biol Rep 2011;38:5327-34.
23. Lu Y, Govindan R, Wang L, Liu PY, Goodgame B, Wen W, et al. MicroRNA profiling and prediction of recurrence/relapse-free survival in stage I lung cancer. Carcinogenesis 2012;33:1046-54.
24. Hua S, Xiaotao X, Renhua G, Yongmei Y, Lianke L, Wen G, et al. Reduced miR-31 and let-7 maintain the balance between differentiation and quiescence in lung cancer stem-like side population cells. Biomed Pharmacother 2012;66:89-97.
25. Lam TK, Shao S, Zhao Y, Marincola F, Pesatori A, Bertazzi PA, et al. Influence of quercetin-rich food intake on microRNA expression in lung cancer tissues. Cancer Epidemiol Biomarkers Prev 2012;21:2176-84.
26. Xiang Q, Tang H, Yu J, Yin J, Yang X, Lei X. MicroRNA-98 sensitizes cisplatin-resistant human lung adenocarcinoma cells by up-regulation of HMGA2. Pharmazie 2013;68:274-81.
27. Fu X, Meng Z, Liang W, Tian Y, Wang X, Han W, et al. miR-26a enhances miRNA biogenesis by targeting Lin28B and Zcchc11 to suppress tumor growth and metastasis. Oncogene 2014;33:4296-306.
28. Kumar MS, Armenteros-Monterroso E, East P, Chakravorty P, Matthews N, Winslow MM, et al. HMGA2 functions as a competing endogenous RNA to promote lung cancer progression. Nature 2014;505:212-7.
29. Lin Y, Jiang G, Liu L, Jiang JX, Chen L, Zhao Y, et al. Management of thoracic esophageal perforation. World J Surg 2014;38:1093-9.
30. Xia Y, Zhu Y, Zhou X, Chen Y. Low expression of let-7 predicts poor prognosis in patients with multiple cancers: A meta-analysis. Tumour Biol 2014;35:5143-8.
31. Alam M, Ahmad R, Rajabi H, Kufe D. MUC1-C Induces the LIN28BàLET-7àHMGA2 Axis to Regulate Self-Renewal in NSCLC. Mol Cancer Res 2015;13:449-60.
32. Tsai CH, Lin LT, Wang CY, Chiu YW, Chou YT, Chiu SJ, et al. Over-expression of cofilin-1 suppressed growth and invasion of cancer cells is associated with up-regulation of let-7 microRNA. Biochim Biophys Acta 2015;1852:851-61.
33. Kundu ST, Nallur S, Paranjape T, Boeke M, Weidhaas JB, Slack FJ. KRAS alleles: The LCS6 3'UTR variant and KRAS coding sequence mutations in the NCI-60 panel. Cell Cycle 2012;11:361-6.
34. Kim M, Chen X, Chin LJ, Paranjape T, Speed WC, Kidd KK, et al. Extensive sequence variation in the 3' untranslated region of the KRAS gene in lung and ovarian cancer cases. Cell Cycle 2014;13:1030-40.
35. Shen LQ, Xie YZ, Qian XF, Zhuang ZX, Jiao Y, Qi XF. A single nucleotide polymorphism in the promoter region of let-7 family is associated with lung cancer risk in Chinese. Genet Mol Res 2015;14:4505-12.
36. Li K, Zhang Q, Zhang Y, Yang J, Zheng J. T-cell-associated cellular immunotherapy for lung cancer. J Cancer Res Clin Oncol 2015;141:1249-58.
37. Makowiecki C, Nolte A, Sutaj B, Keller T, Avci-Adali M, Stoll H, et al. New basic approach to treat non-small cell lung cancer based on RNA-interference. Thorac Cancer 2014;5:112-20.
38. Naidu S, Magee P, Garofalo M. MiRNA-based therapeutic intervention of cancer. J Hematol Oncol 2015;8:68.
39. Slack FJ, Weidhaas JB. MicroRNAs as a potential magic bullet in cancer. Future Oncol 2006;2:73-82.
40. Barh D, Malhotra R, Ravi B, Sindhurani P. MicroRNA let-7: An emerging next-generation cancer therapeutic. Curr Oncol 2010;17:70-80.
41. Trang P, Wiggins JF, Daige CL, Cho C, Omotola M, Brown D, et al. Systemic delivery of tumor suppressor microRNA mimics using a neutral lipid emulsion inhibits lung tumors in mice. Mol Ther 2011;19:1116-22.
42. Wang QZ, Lv YH, Gong YH, Li ZF, Xu W, Diao Y, et al. Double-stranded Let-7 mimics, potential candidates for cancer gene therapy. J Physiol Biochem 2012;68:107-19.
43. Zhong Z, Dong Z, Yang L, Chen X, Gong Z. Inhibition of proliferation of human lung cancer cells by green tea catechins is mediated by upregulation of let-7. Exp Ther Med 2012;4:267-272.
44. Ahmad A, Maitah MY, Ginnebaugh KR, Li Y, Bao B, Gadgeel SM, et al. Inhibition of Hedgehog signaling sensitizes NSCLC cells to standard therapies through modulation of EMT-regulating miRNAs. J Hematol Oncol 2013;6:77.
45. Mironova N, Patutina O, Brenner E, Kurilshikov A, Vlassov V, Zenkova M. MicroRNA drop in the bloodstream and microRNA boost in the tumour caused by treatment with ribonuclease A leads to an attenuation of tumour malignancy. PLoS One 2013;8:e83482.
46. Qiao P, Li G, Bi W, Yang L, Yao L, et al. microRNA-34a inhibits epithelial mesenchymal transition in human cholangiocarcinoma by targeting Smad4 through transforming growth factor-beta/Smad pathway. BMC Cancer 2015;15:469.
47. Stahlhut C, Slack FJ. Combinatorial Action of MicroRNAs let-7 and miR-34 Effectively Synergizes with Erlotinib to Suppress Non-small Cell Lung Cancer Cell Proliferation. Cell Cycle 2015;14:2171-80.